We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-2.1%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$34.1B
AUM Growth
-$2.63B
(-7.2%)
Cap. Flow
-$362M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
13.14%
Holding
2,315
New
186
Increased
813
Reduced
981
Closed
182
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$283M |
| 2 |
Medtronic
MDT
|
+$96M |
| 3 |
Philip Morris
PM
|
+$80.4M |
| 4 |
United Parcel Service
UPS
|
+$75.5M |
| 5 |
Dominion Energy
D
|
+$74.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$178M |
| 2 |
General Mills
GIS
|
+$158M |
| 3 |
ExxonMobil
XOM
|
+$138M |
| 4 |
ServiceNow
NOW
|
+$96M |
| 5 |
Keysight
KEYS
|
+$72.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.14% |
| 2 | Financials | 15.14% |
| 3 | Technology | 13.55% |
| 4 | Consumer Discretionary | 8.1% |
| 5 | Consumer Staples | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Brown & Brown
BRO
$22.5B
| $20.2M | 0.06% |
333,874
-95,029
| -22% | -$5.98M |
|
377
Denali Therapeutics
DNLI
$3.26B
| $20.2M | 0.06% |
656,593
-12,336
| -2% | -$401K |
|
378
Penumbra
PEN
$12.5B
| $20.2M | 0.06% |
106,283
-101
| -0.1% | -$16.2K |
|
379
Moderna
MRNA
$57.4B
| $20.1M | 0.06% |
170,213
+111,644
| +191% | +$16.9M |
|
380
Linde
LIN
$213B
| $20M | 0.06% |
74,104
-138
| -0.2% | -$39.6K |
|
|
AQUA
381
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $19.9M | 0.06% |
602,797
+137,338
| +30% | +$4.99M |
|
|
OPTU
382
Optimum Communications Inc
OPTU
$377M
| $19.9M | 0.06% |
3,410,805
-111,965
| -3% | -$1.07M |
|
|
NOVA
383
DELISTED
Sunnova Energy
NOVA
| $19.9M | 0.06% |
900,571
-93,476
| -9% | -$2.27M |
|
384
Targa Resources
TRGP
$61.3B
| $19.8M | 0.06% |
328,628
+9,341
| +3% | +$614K |
|
385
Enovis
ENOV
$1.03B
| $19.8M | 0.06% |
430,109
+838
| +0.2% | +$45.4K |
|
|
CNR
386
Core Natural Resources Inc
CNR
$4.69B
| $19.8M | 0.06% |
307,968
-42,145
| -12% | -$2.67M |
|
387
Talos Energy
TALO
$3.06B
| $19.8M | 0.06% |
1,186,927
+363,889
| +44% | +$6.52M |
|
388
Murphy USA
MUSA
$9.67B
| $19.8M | 0.06% |
71,842
+14,436
| +25% | +$4.04M |
|
389
Vulcan Materials
VMC
$32.3B
| $19.6M | 0.06% |
124,268
+123,196
| +11,492% | +$20M |
|
390
EXL Service
EXLS
$5.5B
| $19.5M | 0.06% |
660,450
-640,720
| -49% | -$20.9M |
|
391
NVR
NVR
$16.7B
| $19.2M | 0.06% |
4,806
-179
| -4% | -$763K |
|
392
Qorvo
QRVO
$10.4B
| $19.1M | 0.06% |
240,302
+88,910
| +59% | +$8.6M |
|
393
National Vision
EYE
$1.25B
| $19M | 0.06% |
582,806
-87,200
| -13% | -$2.83M |
|
|
CSII
394
DELISTED
Cardiovascular Systems, Inc.
CSII
| $19M | 0.06% |
1,370,755
+542,822
| +66% | +$8.06M |
|
395
Annexon
ANNX
$743M
| $18.9M | 0.06% |
3,057,800
+4,840
| +0.2% | +$26.2K |
|
|
RXDX
396
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $18.9M | 0.06% |
+320,134
| New | +$14.6M |
|
397
Icon
ICLR
$13.3B
| $18.8M | 0.06% |
102,081
-20,997
| -17% | -$4.57M |
|
398
Intuitive Surgical
ISRG
$133B
| $18.8M | 0.05% |
100,040
-463
| -0.5% | -$99.4K |
|
399
AGCO
AGCO
$8.67B
| $18.6M | 0.05% |
193,393
-58,767
| -23% | -$6.12M |
|
400
L3Harris
LHX
$46.5B
| $18.6M | 0.05% |
89,304
-30,565
| -25% | -$7.05M |
|
Similar funds
Federated Hermes's Q3 2022 Portfolio in Review
As of Q3 2022, Federated Hermes held 2,315 positions worth $34.1B, down 7.2% from $36.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q3 2022 filing shows 186 new, 813 increased, 981 reduced and 182 closed positions. Its largest new stake was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M. The largest sale was Cardinal Health, an estimated $178M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 23% a quarter earlier, followed by Financials and Technology.
- Federated Hermes's largest Q3 2022 buy was Amylyx Pharmaceuticals: 1,329,000 shares worth $37.4M.
- Federated Hermes added most to JPMorgan Chase in Q3 2022, an estimated $283M increase.
- Federated Hermes's biggest Q3 2022 reduction was Cardinal Health, cutting an estimated $178M.
- Federated Hermes fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $69.1M.
- Federated Hermes's ten largest holdings make up 13% of its $34.1B portfolio in Q3 2022.
- Federated Hermes opened 186 new positions and closed 182 in Q3 2022.
- Federated Hermes's portfolio value fell 7.2% quarter-over-quarter to $34.1B.
Based on Federated Hermes's 13F filing for Q3 2022, filed 14 Nov 2022.